Policy | July 11, 2025
EU launches strategies to strengthen crisis readiness and health security
The Medical Countermeasures Strategy focuses on strengthening the EU’s preparedness for health crises
The Medical Countermeasures Strategy focuses on strengthening the EU’s preparedness for health crises
The Swiss peptide and oligonucleotide manufacturers roll out major investments across site networks in US, UK and Switzerland
The 16,000-square-foot expansion enhances DuPont’s global sterile operations
The plant will have installed production capacity of 3,120 MT/month
Expanded US manufacturing and R&D presence with investment in 10 facilities, including 7 brand new facilities
L-HPC was independently developed by Shin-Etsu Chemical as a disintegrant for tablets
ALPLA is going to manufacture high-quality plastic bottles, preforms, matching closures and injection-molded parts in Chachoengsao using all core technologies
The facility is equipped with state-of-the-art technology to produce high-quality lyophilized (freeze-dried) products
Construction of the plant will commence in 2025 with first production expected to be in 2027
Subscribe To Our Newsletter & Stay Updated
